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ABSTRACT 25 
Disseminated candidiasis has become one of the leading causes of hospital-26 
acquired blood stream infections with high mobility and mortality. However, the 27 
molecular basis of host defense against disseminated candidiasis remains 28 
elusive, and treatment options are limited. Here, we report that the E3 ubiquitin 29 
ligase CBLB directs polyubiquitination of dectin-1 and -2, two key pattern 30 
recognition receptors for sensing Candida albicans, and their downstream kinase 31 
SYK, thus inhibiting dectin-1/2-mediated innate immune responses. CBLB 32 
deficiency or inactivation protects mice from systemic infection with a lethal dose 33 
of Candida albicans, and deficiency of dectin-1, -2, or both, in Cblb–/– mice 34 
abrogates this protection. Importantly, silencing the Cblb gene in vivo protects 35 
mice from lethal systemic Candida albicans infection. Our data reveal that CBLB 36 
is crucial for homeostatic control of innate immune responses mediated by 37 
dectin-1 and -2. Our data also indicate that CBLB represents a potential 38 
therapeutic target for protection from disseminated candidiasis. 39 
40 
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INTRODUCTION 41 
Candida albicans (C. albicans) infection is the most common cause of fungal 42 
infections in humans and has become one of the leading causes of hospital-43 
acquired blood stream infections. Despite the availability of several anti-fungal 44 
drugs, invasive candidiasis still has a high mortality rate ranging from 45 to 75% 1. 45 
The high morbidity and mortality associated with disseminated candidiasis are 46 
mainly due to the lack of early and accurate diagnostic tools, limited anti-fungal 47 
drugs, and emergence of drug resistance. These factors highlight the need to 48 
further understand host-pathogen interactions and the mechanisms of immune 49 
resistance to fungal spread, and to develop immune-based strategies to combat 50 
candidemia.  51 
 52 
The fungi-responsive C-type lectin receptors (CLRs) play a central role in the 53 
detection of Candida during bloodstream infection. In normal hosts, C. albicans is 54 
controlled by activation of innate immune cells via cell surface pattern recognition 55 
receptors (PRRs) such as Toll-like receptor 2 (TLR2) and CLRs that detect the 56 
infecting fungus. The CLRs dectin-1 and -2 recognize C. albicans yeast cells and 57 
hyphae by binding to surface β-glucans and α-mannans on the two fungal forms, 58 
respectively 2-4. Recognition of these molecules results in the release of 59 
inflammatory cytokines from innate immune cells, which is critical for anti-fungal 60 
immunity 5. However, the regulation of dectin-mediated signaling pathways, 61 
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including SYK, that control the pro-inflammatory response to fungal infection, is 62 
completely unknown.  63 
 64 
Casitas B lymphoma-b (CBLB), a member of the RING finger type E3 ubiquitin 65 
ligases that directs the ubiquitination of an array of signaling proteins 6. We and 66 
others have shown a crucial role for CBLB in T cell activation, tolerance induction, 67 
and TH2/9 cell differentiation 7-14, but its role in innate immune responses is 68 
unclear. In this study, we report that CBLB functions as a negative regulator of 69 
fungal recognition during systemic C. albicans infection by targeting dectin-1, -2, 70 
and SYK for K48-linked polyubiquitination. Negative regulation by CBLB of 71 
dectin-1- and -2-mediated signaling is crucial for restraining the magnitude of 72 
innate immune responses against C. albicans infection, but leads to suboptimal 73 
protection of the host. Systemic in vivo delivery of Cblb siRNA protects C57BL/6 74 
mice from systemic C.albicans infection. Therefore, our data suggest that CBLB 75 
is a potential drug target for systemic candidiasis. 76 
  77 
RESULTS 78 
CBLB inhibits signaling via Dectin receptors  79 
To determine the role of CBLB in innate immune responses we stimulated WT 80 
and Cblb–/– bone marrow-derived macrophages (BMDMs) and BM-derived 81 
dendritic cells (BMDCs) with TLR 1-9 ligands or zymosan (a ligand for TLR2 and 82 
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dectin-1). We found that whereas TLR ligand-induced production of TNF-α and 83 
IL-6 was comparable between WT and Cblb–/– BMDMs and BMDCs, zymosan-84 
induced TNF-α and IL-6 production was significantly higher in Cblb–/– than WT 85 
BMDMs and BMDCs (Supplementary Fig. 1a, b). Given that zymosan activates 86 
both TLR2 and dectin-1 15, this result suggests that CBLB could regulate the 87 
dectin-1 signaling pathway. To directly test this we stimulated WT and Cblb–/– 88 
BMDMs and BMDCs with curdlan, a purified β-glucan which specifically activates 89 
dectin-1 16. Curdlan stimulation induced a significantly higher level of TNF-α and 90 
IL-6 in Cblb–/– than WT BMDMs and BMDCs (Supplementary Fig. 1a,b).  91 
 92 
To confirm this observation, and to determine whether CBLB regulates other 93 
Dectin family members, we infected BMDMs, BMDCs and BM neutrophils from 94 
WT and Cblb–/– mice with a C. albicans yeast-only mutant (cap1; hereafter 95 
referred to as yeast), in which the adenylate cyclase-associated protein-1 gene 96 
was disrupted, causing the failure of yeast-hypha transition due to lack of cAMP 97 
17. Dectin-1 and dectin-2 recognize the yeast and hyphal forms of C. albicans, 98 
respectively, by binding to the surface β-glucans (dectin-1) and α-mannans 99 
(dectin-2) of the two fungal forms 2-4. As shown in Fig. 1a and Supplementary Fig. 100 
2a, CBLB deficiency resulted in increased production of TNF-α and IL-6 by 101 
BMDMs and BMDCs in response to signaling via both the yeast and hyphal 102 
forms of C. albicans infection. In contrast, Cblb–/– neutrophils produced 103 
comparable amounts of TNF-α and IL-6 compared to WT neutrophils, except for 104 
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the 3 h time point after infection (Supplementary Fig. 2b), suggesting that CBLB 105 
may have a limited role in affecting the inflammatory response of neutrophils 106 
against C. albicans infection. Cblb–/– BMDMs also produced more TNF-α and IL-107 
6 than WT BMDMs infected with A. fumigatus conidia (Fig. 1b), a prevalent 108 
fungus that causes potentially lethal infections in immunosuppressed patients 18. 109 
This finding is notable since dectin-1 is a major PRR recognizing A. fumigatus 19-110 
21. Therefore, CBLB has the potential to regulate the dectin family of CLRs in 111 
response to some fungal pathogens. Since several studies indicate that either the 112 
NLRP3 inflammasome or a non-canonical, caspase-8-mediated inflammasome 113 
participates in host defense against C. albicans infection 22, 23, we measured IL-114 
1β production by WT and Cblb–/– BMDMs upon C. albicans yeast and hyphal 115 
infection. Both WT and Cblb–/– BMDMs produced comparable levels of IL-1β (Fig. 116 
1a), suggesting that CBLB does not regulate the inflammasome activation 117 
mediated by dectin-1 or -2.  118 
 119 
A recent report showed that β-glucan of C. albicans induces a strong IL-1RA 120 
response in human peripheral blood mononuclear cells (PBMC), which is 121 
independent of dectin-1 and CR3 24. To test whether CBLB affects the release of 122 
anti-inflammatory stimuli such as IL-1RA, we measured the production of IL-1RA 123 
in BMDMs of WT and Cblb–/– mice upon infection with live C. albicans yeast and 124 
hyphae. Our data showed that there was no significant difference in IL-1RA 125 
release between WT and Cblb–/– BMDMs infected with both forms of C. albicans 126 
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(Fig. 1c). These data suggest that CBLB does not modulate the release of IL-127 
1RA.  128 
 129 
To determine whether CBLB has a similar effect on human macrophages upon C. 130 
albicans infection, human monocyte-derived macrophages (MDMs) were 131 
generated 25, 26, and transfected with Cblb siRNA or scrambled siRNA. 132 
Consistent with the mouse results, we found that silencing Cblb in MDMs 133 
resulted in significantly increased production of TNF-α and IL-6 upon infection 134 
with C. albicans yeast and hyphae, with IL-6 production being the more profound 135 
(Supplementary Fig. 3a, b). These results also correlated with impaired down-136 
modulation of dectin-1 and -2 expression (Supplementary Fig. 3d), thus 137 
indicating that our observations in mouse macrophages can be recapitulated in 138 
human macrophages.  139 
 140 
CBLB associates with dectin-1 and -2 in macrophages upon infection with 141 
C. albicans yeast and hyphal forms 142 
Dectin family CLRs play a major role in fungal recognition and host innate 143 
responses against fungal infection 15, 27, 28. Dectin-1's cytoplasmic tail contains an 144 
ITAM motif that can be phosphorylated by Src family kinases. Phosphorylated 145 
dectin-1 in turn, recruits and activates SYK, thereby initiating downstream 146 
signaling via the CARD9/BCL10/MALT1 complex 15, 28. Since dectin-2 lacks this 147 
ITAM-like motif it binds FcR-γ 3 which contains ITAMs 29 that recruit SYK and 148 
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transduce dectin-2 signaling 30-32. We sought to determine whether and how 149 
CBLB regulates signaling via dectin-1 and -2 during C. albicans infection. First, 150 
we determined whether CBLB physically interacts with dectin receptors or their 151 
signaling intermediates, and if so, how this occurs.  To this end, we infected WT 152 
BMDMs with C. albicans yeast or hyphae for different times. We found that CBLB 153 
was inducibly associated by co-immunoprecipitation with dectin-1, dectin-2, SYK 154 
and CARD9 upon infection with C. albicans yeasts or hyphae (Fig. 2a, b).  155 
 156 
It has previously been shown that CBLB binds to SYK in B cells upon BCR 157 
stimulation 33, or CARMA1 (CARD11), a homologue of CARD9, in NK T cells 34. 158 
To determine whether SYK and CARD9 are potential binding partners of CBLB in 159 
the signaling pathways derived from dectin-1 and -2, we silenced Syk gene 160 
expression in WT BMDMs by Syk siRNA. We found that knocking down Syk 161 
expression did not affect the association of CBLB with either dectin-1 or dectin-2 162 
(Fig. 2c). Similarly, CARD9 deficiency also did not affect CBLB-dectin-1 or 163 
CBLB-dectin-2 association (Fig. 2d). Next we wanted to determine whether 164 
phosphorylation of the ITAM within dectin-1 and the ITAMs within FcR-γ is 165 
required for CBLB association in macrophages upon C. albicans infection (yeasts 166 
and hyphae). To accomplish this, we mutated the tyrosine (Y) of the hemi-ITAM 167 
to phenylalanine (F) in dectin-1’s cytoplasmic tail (Y15F), and the tyrosines within 168 
the ITAMs of the FcR-γ to F (FcR-γY65F,Y76F), then reconstituted Clec7a–/– BMDMs 169 
and Fcerg1–/– BMDMs with these mutants, and infected them with C. albicans 170 
yeast and hyphae, respectively. Mutation of dectin-1 at Y15 or FcR-γ at Y65 and 171 
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Y76 completely abrogated the binding of CBLB to dectin-1 or dectin-2 (Fig. 2e, f), 172 
indicating that phospho-Y15 of dectin-1 or phospho-Y65 and Y76 of FcR-γ is 173 
critical for their binding to CBLB. Indeed, CBLB bound to FcR-γ in WT BMDMs 174 
upon C. albicans hyphal infection (Fig. 2g). 175 
 176 
Dectin-1, dectin-2, and SYK are targets of CBLB 177 
To determine whether dectin-1 and dectin-2, or the downstream signaling 178 
molecules are the targets of CBLB, we first examined protein stability of dectin-1, 179 
dectin-2, SYK and CARD9 in macrophages infected with C. albicans yeast or 180 
hyphae. Interestingly, dectin-1 and -2, but not SYK or CARD9, underwent 181 
degradation in WT BMDMs upon infection with C. albicans yeasts and hyphae, 182 
but not in BMDMs lacking CBLB (Fig. 3a). These findings suggest that dectin 183 
receptors are the likely targets of CBLB. Furthermore, dectin-1 and -2 184 
degradation was completely abrogated by pretreatment with E-64, a lysosome 185 
inhibitor, but not with MG-132, a proteasome inhibitor (Fig. 3b), suggesting that 186 
dectin-1 and -2 undergo lysosome-mediated degradation.  187 
 188 
To further determine whether CBLB is the E3 ubiquitin ligase for dectin-1 or 189 
dectin-2, BMDMs generated from WT, Cblb–/– or mice expressing an E3 ligase 190 
dead mutation (C373A) (CblbC373A) 35 were infected with C. albicans yeast or 191 
hyphae. The CBLB C373A mutation or deficiency abrogated ubiquitination of 192 
dectin-1 and -2 (Fig. 3c,d, upper panel; Supplementary Fig. 4a, b, upper 193 
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panel). To determine whether ubiquitination of dectin-1 or -2 is K48 or K63-linked, 194 
we utilized anti-K48 ubiquitin or anti-K63 ubiquitin antibodies. We confirmed that 195 
both dectin-1 and -2 underwent K48-linked polyubiquitination, and this K48-linked 196 
polyubiquitination of dectin-1- and -2 was abrogated in BMDMs expressing the 197 
CBLB C373A mutation or lacking CBLB (Fig. 3c, d, lower panel; 198 
Supplementary Fig. 4a, b, lower panel; data not shown).  199 
 200 
It was previously shown that CBLB targets SYK for polyubiquitination but not 201 
degradation in B cells 33. To determine whether SYK is also a potential target of 202 
CBLB in macrophages triggered by dectin-1 or -2 receptor-ligand interactions, we 203 
examined SYK ubiquitination in WT and CblbC373A BMDMs upon infection with C. 204 
albicans yeast or hyphae. Indeed, SYK underwent K48-linked polyubiquitination 205 
upon infection with both C. albicans yeast and hyphae, but this ubiquitination was 206 
greatly reduced in BMDMs expressing C373A CBLB (Supplementary Fig. 4c, d). 207 
Therefore, our data suggest that dectin-1/2 and SYK are targets of CBLB, and 208 
that CBLB keeps the expression of these CLRs in check. Consistent with these 209 
data, SYK and NF-κB were highly activated in BMDMs lacking CBLB upon C. 210 
albicans yeast and hyphal infection (Supplementary Fig. 4e). 211 
 212 
To examine the functional relevance of CBLB-mediated ubiquitination of dectin-1 213 
and -2 we generated single and triple K to R mutations of dectin-1K2R, dectin-214 
1K27R, dectin-1K34R, and dectin-1K2R,K27R,K34R and dectin-2K10R by site-directed 215 
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mutagenesis.  We reconstituted BMDMs lacking dectin-1 (from Clec7a–/– mice) 216 
with WT dectin-1 or dectin-1 K/R mutants and BMDMs lacking dectin-2 (from 217 
Clec4n–/– mice) with WT dectin-2 or dectin-2K10R mutant by Lipofectamine 218 
transfection, and infected them with C. albicans yeast or hyphae. Reconstituting 219 
Clec7a–/– BMDMs with WT dectin-1 or dectin-1K2R,K27R,K34R completely or partially 220 
restored Dectin-1 ubiquitination, whereas dectin-1K2R,K27R,K34R mutants were not 221 
ubiquitinated (Fig. 3e). As expected, Clec4n–/– BMDMs reconstituted with WT 222 
dectin-2 but not dectin-2K10R mutant restored ubiquitination of dectin-2 (Fig. 3f). 223 
These data indicate that dectin-1 K2, K27, and K34, and dectin-2 K10 are the 224 
sites of ubiquitination of dectin-1 and -2, respectively.  Consistent with these data, 225 
Clec7a–/– BMDMs reconstituted with dectin-1K2R,K27R,K34R, or Clec4n–/– BMDMs 226 
reconstituted with dectin-2K10R, produced significantly higher amounts of TNF-α 227 
and IL-6 upon infection with C. albicans yeast or hyphae (Fig. 3g, h). 228 
 229 
CBLB regulates the internalization of dectin-1 and -2, and their trafficking 230 
to the lysosome 231 
Cell surface receptor internalization can occur when receptors are mono- or poly-232 
ubiquitinated following ligand-induced activation, and subsequently sorted into 233 
endocytic vesicles for delivery to the lysosome for degradation 36-38. 234 
Internalization of dectin-1 has been shown to terminate inflammatory responses 235 
in order to keep inflammation in check 39. Thus, impaired down-modulation of 236 
dectin-1 and -2 could be due to a lack of internalization or a block in intracellular 237 
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vesicle sorting to the lysosome. To determine whether CBLB is critical for this 238 
process, the cell surface and internalized expression levels of dectin-1 and 239 
dectin-2 in BMDMs from WT and Cblb–/– mice was investigated. We found a 240 
minimal level of intracellular dectin-1 or -2 in Cblb–/– BMDMs (Fig. 4a,b), 241 
suggesting that CBLB promotes internalization of dectin-1 or dectin-2 after 242 
infection with C. albicans yeast or hyphae. 243 
 244 
We next investigated whether retention of ligand-engaged dectin-1 or -2 in Cblb–245 
/– BMDMs is due to impaired sorting of endosomal vesicles to lysosomes. We 246 
compared the subcellular localization of ligand-engaged dectin-1 or -2 in WT and 247 
Cblb–/– BMDMs by confocal microscopy. In support of impaired lysosomal 248 
degradation of dectin-1 and -2 in BMDMs lacking CBLB, intracellular trafficking of 249 
internalized dectin-1 or -2 to the lysosome was significantly reduced in the 250 
absence of CBLB (Fig. 4c, d).  251 
 252 
CBLB negatively regulates ROS production and fungal killing but not 253 
phagocytosis of C. albicans  254 
Neutrophils and macrophages are professional phagocytes of the innate immune 255 
system that are essential in controlling bacterial and fungal infections by 256 
phagocytosis and killing mechanisms 40. The production of highly reactive oxygen 257 
species (ROS) is one of the primary effector mechanisms used by phagocytes to 258 
control or clear microbial infections. ROS plays an important role in the initial step 259 
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of fungal killing in phagosomes 41 and can be potentiated by dectin signaling. We 260 
measured ROS production by co-culturing the C. albicans yeast cap1/cap1 261 
mutant or hyphae with WT or Cblb–/– BMDMs. We found that Cblb–/– and 262 
CblbC373A BMDMs produced more ROS than WT controls at MOIs of 5:1 and 2:1 263 
(Supplementary Fig. 5a).  Enhanced ROS activity in Cblb–/– BMDMs correlated 264 
with an increase in their fungal killing potency (Supplementary Fig. 5b). 265 
Consistent with a limited role of CBLB in pro-inflammatory cytokine production by 266 
neutrophils, we did not observe a significant increase in ROS activity and fungal 267 
killing in neutrophils isolated from the BM of Cblb–/– or CblbC373A mice compared 268 
to WT controls (Supplementary Fig. 5c).  However, phagocytosis of C. albicans 269 
by Cblb–/– BMDMs was not increased compared to WT BMDMs (Supplementary 270 
Fig. 5d).  271 
 272 
CBLB inhibits innate immune responses against systemic C. albicans 273 
infection mediated by the dectin family of CLRs 274 
The recognition of β-glucans and α-mannans by dectin-1 and dectin-2 275 
respectively is thought to trigger immune responses that are primarily designed 276 
for the control of fungal pathogens 2-4. To assess the role of CBLB in anti-fungal 277 
immunity we infected WT, Cblb–/–, and CblbC373A mice with a lethal dose of C. 278 
albicans to monitor survival, and a sub-lethal dose to measure serum cytokines 279 
and fungal burden. We found that most Cblb–/– and CblbC373A mice were 280 
protected from lethal systemic infection with C. albicans (Fig. 5a), which 281 
correlated with heightened levels of TNF-α and IL-6 in the sera of Cblb–/– and 282 
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CblbC373A mice, lower fungal burden in the kidney, lung, spleen, and liver, and 283 
decreased C. albicans hyphae in the kidney on day 2 as assessed by PAS 284 
staining (Fig. 5b-d; Supplementary Fig. 6a). We also observed multifocal 285 
tubulointerstitial nephritis in WT mice infected with C. albicans, which was 286 
ameliorated in mice lacking CBLB or expressing the CBLB C373A mutation (Fig. 287 
5c). This observation is consistent with fact that more immune cells traffic to the 288 
kidneys in WT than CblbC373A mice including macrophages, dendritic cells (DCs), 289 
and neutrophils (Supplementary Fig. 6b). Improved survival rate was also 290 
observed in Rag1–/–Cblb–/– mice that lack functional adaptive immune cells (Fig. 291 
5e), supporting a critical role of CBLB in down-regulating innate immune 292 
responses.   293 
 294 
To further determine whether monocytes, macrophages and neutrophils have a 295 
greater  capacity to kill C. albicans during systemic infection, we monitored fungal 296 
burden in the blood of WT and CblbC373A mice at 2 and 6 h after infection. We 297 
found that fungal burden in the blood of CblbC373A mice was significantly lower 298 
than that of WT mice at 2 and 6 h after infection (Supplementary Fig. 7a). The 299 
lower fungal burden in the blood of CblbC373A mice correlated with enhanced 300 
fungal killing activity by PBMCs, but not by neutrophils of CblbC373A mice 301 
(Supplementary Fig. 7a). Increased fungal killing was also observed in 302 
monocytes from the spleen of CblbC373A mice (Supplementary Fig. 7b). We also 303 
monitored ROS activity in monocytes, macrophages and neutrophils from WT 304 
and CblbC373A spleens and kidneys by CellRox dye. As shown in Supplementary 305 
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Figure 7c, monocytes and macrophages, but not neutrophils, displayed 306 
augmented ROS expression in C. albicans-infected CblbC373A mice when they 307 
were infected in vitro with C. albicans. Consistent with the lower fungal burden 308 
and less inflammation in CblbC373A kidneys, trafficking of CD45.2+ leukocytes, 309 
including macrophages, DCs and neutrophils to CblbC373A kidneys were 310 
significantly reduced (Supplementary Fig. 6b). Even with decreased myeloid 311 
cells in CblbC373A kidneys upon infection with C. albicans, we observed an 312 
increase in ROS expression in monocytes and macrophages, and fungal killing 313 
using CD45+ cells isolated from CblbC373A kidneys (Supplementary Fig. 7d), and 314 
increased TNF-α and IL-6 in the kidney homogenates of CblbC373A mice 315 
(Supplementary Fig. 7e).   316 
 317 
To further determine whether heightened inflammatory responses caused by 318 
CBLB deficiency are mediated by dectin-1 and -2, we generated Cblb–/–Clec7a–/–, 319 
Cblb–/–Clec4n–/–, and Cblb–/–Clec7a–/–Clec4n–/– mice. We infected WT, Cblb–/–, 320 
Clec7a–/–, Cblb–/–Clec7a–/–, Clec4n–/–, Cblb–/–Clec4n–/–, and Cblb–/–Clec7a–/–321 
Clec4n–/– mice with C. albicans. Dectin-1 or dectin-2 single deficiency rendered 322 
Cblb–/– mice susceptible to C. albicans infection, and dectin-1 and dectin-2 323 
double deficiency greatly increased the sensitivity of Cblb–/– mice to systemic C. 324 
albicans infection. All of the triple knockout mice died within four days after 325 
infection at a dose at which all Cblb–/– mice survived (Fig. 5f), which correlated 326 
with significantly lower levels of TNF-α and IL-6 in their sera and fungal burden in 327 
the kidneys (Supplementary Fig. 8a,b). Therefore, our results suggest that 328 
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CBLB negatively regulates both dectin-1 and -2, and that CBLB dampens 329 
inflammatory responses mediated by dectin-1 and -2 during systemic fungal 330 
infection. Notably,  Cblb–/– or CblbC373A mice at 8-12 weeks of age did not display 331 
signs of autoimmunity as revealed by comparable anti-dsDNA and anti-ssDNA 332 
antibody titers and IL-17/IFN-γ in the sera of WT and Cblb–/– or CblbC373A mice, 333 
and no elevated IL-17 and IFN-γ in the kidneys of Cblb–/– or CblbC373A mice 334 
compared to WT mice (Supplementary Fig. 9a-d). These data suggest that a 335 
pre-existing  autoimmunity in Cblb–/– or CblbC373A mice does not account for 336 
differences relative to WT mice after fungal infection. 337 
 338 
We also observed that Clec7a–/– and Clec4n–/– mice die at a similar rate upon 339 
systemic C. albicans infection, suggesting that both dectin-1 and dectin-2 are 340 
equally important for fungal recognition (Fig. 5f). Since Cblb–/–Clec7a–/–, Cblb–/– 341 
Clec4n–/–, and Cblb–/–Clec7a–/–Clec4n–/– mice did not die at the same rate after 342 
infection as did Clec7a–/–, Clec4n–/–, or Clec7a–/–Clec4n–/– mice (Fig. 5f), these 343 
results suggest that CBLB may regulate an additional CLR(s) such as the 344 
mannose receptor (MR), dectin-3 or Mincle which have been shown to be 345 
involved in host defense against C. albicans infection 4, 42-44.  Indeed, loss of 346 
CBLB appeared to stabilize the protein expression of dectin-3, but not MR, 347 
Mincle and DC-SIGN (Supplementary Fig. 10).  348 
 349 
CBLB is a potential therapeutic target for anti-fungal infection 350 
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Since CBLB down-regulates dectin family CLR signaling and host innate immune 351 
responses, decreasing CBLB expression may enhance phagocyte anti-fungal 352 
responses providing evidence for a new therapeutic approach. We performed 353 
experiments using in vivo delivery of Cblb siRNA to knock down Cblb. We first 354 
infected WT mice with C. albicans by i.v. injection, and 24 h later we injected 355 
Cblb siRNA or a nonsense siRNA via the tail vein. Mortality of the mice was 356 
monitored for 7 days. While all WT mice treated with nonsense siRNA died within 357 
7 days after infection, 7 out of 9 WT mice treated with Cblb siRNA survived. 358 
There was a significantly higher fungal burden in the kidneys of WT mice 359 
receiving the nonsense siRNA compared to those receiving Cblb siRNA (Fig. 6). 360 
These data indicate that CBLB may serve as a potent therapeutic target for 361 
enhancing host defense against fungal infections. 362 
 363 
DISCUSSION 364 
The fungal cell wall consists mainly of carbohydrates, including mannose-based 365 
structures (the mannoproteins), β-glucan, and chitin. Recognition of β-glucans 366 
and α-mannans by dectin-1 and -2 is essential for anti-fungal immunity 27. 367 
However, the regulation of dectin family receptors is unknown. Here we show 368 
that CBLB functions as a negative regulator of dectin-1 and -2 CLRs which 369 
initiate innate immune responses to fungal pathogens in human and mouse 370 
macrophages. CBLB targets dectin-1 and -2, and SYK for K48-linked 371 
polyubiquitination, which inhibits dectin-1/2-mediated signaling pathways. CBLB 372 
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deficiency or inactivation leads to increased pro-inflammatory responses that 373 
decrease dissemination of C. albicans and bolster host defense.  374 
 375 
To our knowledge, our findings are the first to identify a negative regulator of 376 
dectin receptor-mediated innate immune responses. We show that dectin-1K2R, 377 
K27R, K34R and dectin-2K10R mutations, which abrogate their ubiquitination, result in 378 
increased production of TNF-α and IL-6 by macrophages infected with C. 379 
albicans yeast or hyphae (Fig. 3g,h), thus mirroring the data obtained from Cblb–380 
/– and CblbC373A mice. Our data therefore provide evidence that ubiquitination of 381 
dectin-1 and -2 is a key mechanism for terminating innate immune responses 382 
during fungal infection, thus avoiding excessive inflammation and subsequent 383 
tissue damage while at the same time damping optimal host defense properties.  384 
 385 
Phagocytosis is a key cellular process, both during homeostasis and upon 386 
infection or tissue damage, and dectin-1 has been shown to be a phagocytic 387 
receptor 45. ROS production by phagocytes is associated with pathogen killing 46  388 
and it was reported that dectin-1 activates SYK in macrophages and is important 389 
for dectin-1-stimulated ROS production, but not for phagocytosis 47. Consistent 390 
with this report, our data show that CBLB regulates both dectin-1 and -2 391 
expression and ROS production by macrophages, but does not affect fungal 392 
phagocytosis (Supplementary Fig. 5). Our data suggest that additional 393 
receptor(s) such as Fcγ receptor family or DC-SIGN 44, 45, independent of 394 
regulation by CBLB, may be involved in controlling fungal phagocytosis.  395 
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 396 
Since CBLB is critical for T cell activation, tolerance induction and TH2/9 cell 397 
differentiation 6, it is possible that the enhanced anti-fungal immunity in the 398 
absence of CBLB may result in heightened adaptive T cell responses. However, 399 
this possibility is excluded by the fact that the phenotype of Cblb–/–Rag1–/– mice 400 
upon C. albicans infection, which do not have T and B cells, phenocopies that of 401 
Cblb–/– mice (Fig. 5e), supporting the notion that CBLB is crucial for controlling 402 
innate immune responses against systemic C. albicans infection. We also further 403 
demonstrate that the heightened innate immune responses observed during 404 
systemic C. albicans infection is mediated by dectin-1 and -2 because 405 
introducing dectin-1 or -2 deficiency, or both into Cblb–/– mice abrogates these 406 
heightened responses, and renders Cblb–/– mice susceptible to C. albicans 407 
infection (Fig. 5f; Supplementary Fig. 8a). More importantly, systemic in vivo 408 
delivery of Cblb siRNA to C57BL/6 mice protects them from lethal systemic C. 409 
albicans infection (Fig. 6). These data suggest that CBLB is a potential 410 
therapeutic target for controlling disseminated candidiasis. Of note, inhibition of 411 
CBLB may have detrimental effects due to unchecked inflammation, particularly 412 
on patients in intensive care. However, inhibition of Cblb by siRNA in vivo has a 413 
limited half-life,  and dosages could be modulated to minimize the degree of 414 
inflammation. In addition, no signs of autoimmunity were observed in Cblb–/– or 415 
CblbC373A mice (Supplementary Fig. 9). However, given that we have shown 416 
that Cblb–/– mice develop severe airway inflammation, and an aberrant TH2 417 
response using ovalbumin-induced asthma model 14, it would be interesting to 418 
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test whether mice deficient for CBLB or expressing the CBLB C373A mutation 419 
are susceptible to allergic bronchopulmonary aspergillosis in the future. 420 
 421 
In summary, our data provide the first evidence that CBLB plays an essential role 422 
in regulating dectin-mediated innate immune responses to fungal pathogens 423 
following inflammatory responses to fungi in immunocompetent hosts. One 424 
consequence of this dampening of inflammatory responses is the creation of a 425 
less than optimal host defense program. Targeting CBLB may therefore serve as 426 
a new therapeutic strategy in fighting fungal infections. 427 
 428 
 429 
 430 
 431 
 432 
 433 
 434 
 435 
 436 
 437 
 438 
 439 
 440 
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Figure legends 650 
Figure 1.  CBLB inhibits pro-inflammatory cytokine production by macrophages 651 
upon infection with C. albicans yeast or hyphae and A. fumigatus conidia. (a) 652 
ELISA of TNF-α, IL-6, and IL-1β production in the supernatants collected from 653 
BMDMs of WT and Cblb–/– mice infected with C. albicans yeast cap1 mutant 654 
(thereafter yeast) and hyphal forms (WT strain SC5314) (MOI: 1:1) for 1 and 3 h. 655 
For preparation of hyphae, washed yeast cells were counted, re-suspended in 656 
RPMI-1640 medium, grown in 12-well plates at 37 °C for 3 h, and washed three 657 
times with PBS. (b) ELISA of TNF-α and IL-6 production in the supernatants 658 
collected from BMDMs of WT and Cblb–/– mice infected with swollen A. 659 
Fumigatus conidia (AF293) (MOI = 1:1) for 2 and 4 h. (c) ELISA of IL-1RA 660 
production in the supernatants collected from BMDMs of WT and Cblb–/– mice 661 
infected with C. albicans yeast and hyphal forms.  For all ELISA experiments 662 
data are representative of three independent experiments (biological replicates). 663 
Error bars are mean ± s.d. *P < 0.05, **P < 0.01; unpaired two-tailed Student’s t 664 
test. n = 3 per group, each with three repeated wells. 665 
 666 
Figure 2. CBLB associates with dectin-1 and dectin-2 in macrophages upon C. 667 
albicans yeast and hyphal infection. (a,b) Immunoblot analysis of dectin-1 or 668 
dectin-2, SYK, and CARD9 after immunoprecipitation (IP) with CBLB antibodies 669 
from lysates of BMDMs uninfected or infected with C. albicans yeast or hyphae. 670 
Images are representative of three independent experiments (biological 671 
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replicates), and each IP was blotted separately. (c,d) Immunoblot analysis of 672 
dectin-1 or dectin-2, SYK and CARD9 after immunoprecipitation (IP) of proteins 673 
with CBLB antibodies from lysates of WT BMDMs with or without Syk gene 674 
silencing (c) or WT and Card9–/– BMDMs (d) uninfected or infected with C. 675 
albicans yeast or hyphae. Images are representative of two independent 676 
experiments (biological replicates), and each IP was blotted separately. (e) 677 
Immunoblot analysis of dectin-1 after CBLB immunoprecipitation from lysates of 678 
Clec7a–/– BMDMs reconstituted with Flag-tagged dectin-1 or dectin-1Y15F mutant, 679 
and infected with C. albicans yeast. Images are representative of three 680 
independent experiments (biological replicates), and each IP was blotted 681 
separately.  (f) Immunoblot analysis of dectin-2 after CBLB immunoprecipitation 682 
from lysates of Fcer1g–/– BMDMs reconstituted with Flag-tagged FcR-γ or FcR-683 
γY65F,Y76F mutant, and infected with C. albicans hyphae. Images are 684 
representative of two independent experiments (biological replicates), and each 685 
IP was blotted separately. (g) Immunoblot analysis of FcR-γ after CBLB 686 
immunoprecipitation from lysates of WT and Fcer1g–/– BMDMs infected with C. 687 
albicans hyphae. Images are representative of three independent experiments 688 
(biological replicates), and each IP was blotted separately. 689 
 690 
Figure 3. CBLB targets dectin-1 and dectin-2 for polyubiquitination and 691 
subsequent degradation in the lysosome. (a) Immunoblot analysis of lysates of 692 
WT and Cblb–/– BMDMs infected with C. albicans yeast and hyphal forms (MOI = 693 
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1:1) with antibodies against dectin-1, dectin-2, SYK, CBLB, and ACTIN, 694 
respectively. Images are representative of five independent experiments 695 
(biological replicates). (b) Immunoblot analysis of WT BMDMs pretreated with E-696 
64 (10 μM), MG-132 (5 μM), or both for 30 min, then infected with C. albicans 697 
yeast or hyphae (MOI = 1:1), with antibodies against to dectin-1 and dectin-2, 698 
respectively. Images are representative of three independent experiments 699 
(biological replicates). (c, d) Immunoblot analysis of dectin-1 and dectin-2 700 
ubiquitination of dectin-1 or dectin-2 immunoprecipitates isolated from BMDMs 701 
from WT and CblbC373A mice infected with C. albicans yeast and hyphae, 702 
respectively, by anti-ubiquitin and anti-K48 ubiquitin antibodies. Images are 703 
representative of four independent experiments (biological replicates), and each 704 
IP was blotted separately. (e) Ubiquitination of dectin-1 in Clec7a–/– BMDMs 705 
reconstituted with WT dectin-1 or dectin-1K2R, dectin-1K27R, dectin-1K34R mutant, 706 
or dectin-1K2R, K27R, K34R triple mutant infected with C. albicans yeast. Images are 707 
representative of three independent experiments (biological replicates), and each 708 
IP was blotted separately. (f) Ubiquitination of dectin-2 in Clec4n–/– BMDMs 709 
reconstituted with WT dectin-2 or dectin-2K10R infected with C. albicans hyphae. 710 
Images are representative of three independent experiments (biological 711 
replicates), and each IP was blotted separately. (g, h) ELISA of TNF-α and IL-6 712 
production by Clec7a–/– BMDMs reconstituted with WT dectin-1 or dectin-713 
1K2R,K27R,K34R infected with C. albicans yeast (g), or by Clec4n–/– BMDMs 714 
reconstituted with WT dectin-2 or dectin-2K10R infected with C. albicans hyphae 715 
(h). Data are representative of three independent experiments (biological 716 
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replicates). Error bars are mean ± s.d. *P < 0.05, **P < 0.01; unpaired two-tailed 717 
Student’s t test. n = 3 per group, each with three repeated wells. 718 
 719 
Figure 4.  Loss of CBLB impairs dectin-1 and dectin-2 internalization and their 720 
down-regulation at the cell surface. (a,b) Cell surface and intracellular expression 721 
of dectin-1 and dectin-2 of WT and Cblb–/– BMDMs infected with C. albicans 722 
yeast or hyphae (MOI = 1:1) for times indicated by flow cytometry. For 723 
internalization of dectin-1 and dectin-2, WT and Cblb–/– BMDMs were treated with 724 
acid buffer to strip the antibodies remaining at the cell surface after infection at 725 
each time-point. Data are representative of three independent experiments 726 
(biological replicates). Error bars are mean ± s.d. *P < 0.05; unpaired two-tailed 727 
Student’s t test. n = 3 per group, each with three repeated wells. (c,d) Confocal 728 
image of dectin-1 and dectin-2 internalization and lysosome sorting of WT and 729 
Cblb–/– BMDMs infected or uninfected with C. albicans yeast (c) or hyphae (d) 730 
(MOI = 1:1) for 30 min. Images are representative of five independent 731 
experiments (biological replicates). n = 3 per group, each with three repeated 732 
wells. Scale bar, 5 μm.  733 
 734 
Figure 5. Introducing dectin-1 and dectin-2 deficiency, or double deficiency into 735 
Cblb–/– mice renders Cblb–/– mice susceptible to systemic C. albicans infection. 736 
(a) Kaplan-Meier Survival curve of WT, Cblb–/–, and CblbC373A mice (n = 10 per 737 
group) infected with 5 x 105 CFU of C. albicans (SC5314), and monitored for 7 738 
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days for survival. Data are representative of three independent experiments 739 
(biological replicates). *P < 0.05; Log-rank test. (b) CFU assay of paired kidneys 740 
of WT, Cblb–/– and CblbC373A mice (n = 10 per group) infected with 1 x 105 CFU of 741 
C. albicans performed at day 2 after infection. Data are representative of three 742 
independent experiments (biological replicates). **P < 0.01; unpaired two-tailed 743 
Student’s t test. (c) Kidney histopathology analysis by H&E and PAS staining. 744 
Fungal burden (hyphae) in the kidneys visualized by PAS staining. Images are 745 
representative of two independent experiments (biological replicates). n = 10 per 746 
group. Scale bar, 200 μm. (d) ELISA of serum TNF-α, IL-6, and IL-1β levels of 747 
WT and Cblb–/– mice (n = 10 per group) infected with 1 x 105 CFU of C. albicans 748 
at 2, 6, 12, and 24 h after infection. Data are representative of three independent 749 
experiments (biological replicates). Error bars are mean ± s.d. *P < 0.05, **P < 750 
0.01; unpaired two-tailed Student’s t test. Each with three repeated wells. (e) 751 
Survival rate of Rag1–/– and Rag1–/–Cblb–/– mice (n = 8). infected with 1 x 105 752 
CFU of C. albicans. Data are representative of three independent experiments 753 
(biological replicates). *P < 0.05, Log-rank test. (f) Survival rate of WT, Cblb–/–, 754 
Clec7a–/–, Clec4n–/–, Cblb–/–Clec7a–/–, Cblb–/–Clec4n–/–, and Cblb–/–Clec7a–/–755 
Clec4n–/– mice (n = 5 per group) infected with C. albicans (3.5 x 105 CFU) by i.v. 756 
injection. Data are representative of three independent experiments (biological 757 
replicates).  #P < 0.01, Cblb–/– vs. all other groups; *P < 0.05, Cblb–/–Clec7a–/– vs. 758 
Clec7a–/– or Cblb–/–Clec4n–/– vs.  Clec4n–/–; and §P < 0.05, Cblb–/– Clec7a–/– 759 
Clec4n–/–  vs Clec7a–/– Clec4n–/–; Log-rank test.  760 
 761 
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Figure 6. Systemic in vivo delivery of Cblb siRNA into C57BL/6 mice protects 762 
them from lethal disseminated candidiasis. (a) Survival of C57BL/6 mice treated 763 
with in vivo grade Cblb siRNA (5’-AAAUUCUCGAAGUAUGCUCUU-3’) or a non-764 
sense siRNA (2 mg/kg/mouse) via tail vein injection 24 h after infection with C. 765 
albicans (5 x 105 CFU). Data are representative of three independent 766 
experiments (biological replicates). *P < 0.05, Log-rank test. n = 9 per group. (b) 767 
Fungal burden in the kidneys on day 2 after infection. Data are representative of 768 
three independent experiments (biological replicates). Error bars are mean ± s.d. 769 
*P < 0.05; unpaired two-tailed Student’s t test. n = 9 per group. (c) Immunoblot 770 
analysis of spleen cells from control siRNA or Cblb siRNA-treated C57BL/6 mice 771 
with anti-CBLB and anti-actin, respectively. Data are representative of four 772 
independent experiments (biological replicates). n = 3 per group. 773 






